Phreesia Inc (PHR) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease

A new survey in partnership with the National Kidney Foundation finds that discussions between patients and providers, and patient activation...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Phreesia Announces First Quarter Fiscal 2025 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024. "I...

Form 8-K - Current report

Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner

Phreesia, a leader in patient intake, outreach, and activation, has joined the MEDITECH Alliance Program, an ecosystem of partner organizations...

Phreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100

Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Amy Patel, MPH, Director of Analytics...